ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Tr1X
The Principal Scientist leads the design, development, and optimization of lipid nanoparticle (LNP) formulations and processes to support Tr1X's in vivo CAR‑Treg platform, advancing targeted LNP delivery systems from early research through IND‑enabling stages. This role involves hands‑on formulation work, analytical method development, and cross‑functional collaboration to drive scalable, high‑quality nanoparticle production.
Tr1X is a clinical-stage biotechnology company engineering a novel class of regulatory T cell-based therapies to cure autoimmune and inflammatory diseases. Leveraging cutting-edge genetic engineering and deep immunology expertise, Tr1X develops allogeneic, off-the-shelf Tr1/Treg cell therapies designed to restore immune tolerance and reset the immune system. The company has four active clinical programs spanning Crohn's disease, multiple sclerosis, graft-versus-host disease prevention following stem cell transplant, and autoimmune uveitis.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tr1X.
38% above the average for this role